Document is current
Any future updates will be listed below
-
Authors
Lahm, Harald
Dreßen, Martina
Beck, Nicole
Doppler, Stefanie
Deutsch, Marcus-André
Matsushima, Shunsuke
Neb, Irina
König, Karl Christian
Sideris, Konstantinos
Voss, Stefanie
Eschenbach, Lena
Puluca, Nazan
Deisenhofer, Isabel
Doll, Sophia
Holdenrieder, Stefan
Mann, Matthias https://orcid.org/0000-0003-1292-4799
Lange, Rüdiger
Krane, Markus
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (KR3770/7-1, KR3770/9-1, KR3770/11-1)
Deutsches Zentrum für Herz-Kreislaufforschung (B 15-005, B 15-039SE, 16-006 SE)
- License Information
-
More Information
Article History
Received: 8 March 2019
Accepted: 20 June 2019
First Online: 10 July 2019
Competing Interests
: H.L., M.D., St.D., R.L. and M.K. are holders of a patent (No. 18 164 958.3) for MYBPHL as a biomarker for heart muscle damage. All other authors declare no competing interests.
